Rolfo, C. D., Redman, M. W., Gadgeel, S. M., Minichiello, K., Highleyman, L., Waqar, S. N., Herbst, R. S., Stinchcombe, T., Higgins, K. A., Brahmer, J. R., Reckamp, K. L., Borghaei, H., Gray, J. E., Gandara, D. R. (2026). A phase II study of amivantamab hyaluronidase in
                    <i>MET</i>
                    amplification–positive stage IV or recurrent non–small cell lung cancer (Lung-MAP Sub-Study).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps8680